SHAHZAD MALIK

Profile

First Name

: SHAHZAD

Middle Name

:

Last Name

: MALIK

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-14 
D
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-14 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-07 
D
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-05 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-07-02 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-06-05 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
D/A
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-12 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-12 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-12 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-07 
D/A
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-28 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-28 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-02-14 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-14 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-12-31 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-04 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-09-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-07-08 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-26 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-18 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2015-02-20 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-13 
D/A
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-09 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-13 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-07 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-01 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-08 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-22